About
Technology
Issues
FAQ
Links
Official Page
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.